Almost every biotech are currently experiencing problems with patient recruitment. If they can just tap into 1%, with an “average recruitment contract AUD of $92K,” you won’t find this co trading below a billion dollars in Mcap. Good to see revenue increasing
3mill mcap is a joke
Looking forward to the following; - “next feature release milestone due October 2022” - ISO and HIPPA certification - “Release user dashboard for UAT due December 2022”
OPL Price at posting:
6.0¢ Sentiment: None Disclosure: Not Held
